跳至主要内容
临床试验/NL-OMON38279
NL-OMON38279已完成不适用

Pressure-controlled Intermittent Coronary Sinus Occlusion in Patients with ST-segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: Safety and Feasibility Study - Prepare RAMSES

Miracor Medical Systems GmbH0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1.First time anterior STEMI defined by the following:
  • a.Symptoms of myocardial ischemia > 30 minutes and < 12 hours.
  • b.ST-segment elevation > 1mm (> 0.1 mV) in two contiguous precordial leads in the anterior territory on a 12-lead ECG.
  • 2.Uncomplicated PCI of a LAD culprit lesion
  • (defined as angioplasty followed by stent placement or direct stenting without the occurrence of an adverse event(s) that would preclude further study participation, such as major bleeding, perforation, hypotension, pulmonary edema or instability that in the judgement of the operator preclude participation in the trial)

排除标准

  • 1.Younger than 18 years of age
  • 2.Hospitalization with a primary diagnosis of acute myocardial infarction (AMI) previously or has evidence of previous Q-wave infarct
  • 3.Left main coronary artery culprit lesion
  • 4.Additional stenosis in the LAD for which PCI or CABG is likely to be needed in the next 6 months and which is not treated during the index procedure
  • 5.Cardiogenic shock (systolic blood pressure *90 mmHg in spite of conservative measures) or pulmonary edema (O2 saturation <90% by pulse oximetry and the presence of rales or crackles)
  • 6.Cardiac arrest requiring chest compression or resuscitation
  • 7.Anatomical complications limit capacity to place PICSO Impulse device or achieve stable catheter placement or occlude coronary sinus
  • 8.Known renal disease (GFR < 30 mL/min/1.73m2) or dialysis
  • 9.History of stroke, TIA or reversible ischemic neurological disease within last 6 months
  • 10.Left bundle branch block
  • 11.Known contra-indication for magnetic resonance imaging (Metallic implant precluding MRI, claustrophobia, obesity precluding MRI, etc.)
  • 12.Presence of any lead in the coronary sinus
  • 13.Active or treated malignancies in the last 12 months
  • 14.Previous coronary artery bypass graft surgery
  • 15.Known severe anemia (Hgb < 10 g/dL or < 6.2 mmol/L)
  • 16.Known platelet count < 100,000, known coagulopathy or bleeding diathesis, or unwilling to accept transfusions
  • 17.Participation in another ongoing clinical study
  • 18.Women of child-bearing age
  • 19.Non-cardiac comorbidities and life expectancy < 1 year
  • 20.Legal incompetence
  • 21.A condition that, in the opinion of the Investigator, precludes participation, including compliance with all follow-up procedures

研究者

发起方
Miracor Medical Systems GmbH

相似试验